The stock's fall snapped a two-day winning streak.

Shares of Waters Corp. slid 3.16% to $287.53 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.01% to 6,296.79 and Dow Jones ...

DHR's Q2 results are likely to reflect Life Sciences weakness, but strength in Biotechnology & Diagnostics units and Abcam acquisition add upside potential.

Danaher Corporation (DHR) recently disclosed $70,000 in lobbying efforts, focusing on life sciences and biotechnology. This ...